A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder The purpose of the study is to assess whether treatment with SR58611A can prevent relapse of depressive symptoms in patients with major depressive disorder. Relapse will be assessed using ...

• Country Argentina, Bulgaria, Croatia, Czech Republic, Finland, France, Mexico, Poland, Romania, Russian Federation, Serbia, Slovakia, South Africa
• organs None
• Specialty None

Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients In order to obtain information on a wider range of doses of GW642444 (a possible new medication to treat asthma) than has been previously examined in asthmatic patients, this current study...

• Country Germany, New Zealand, Russian Federation, Sweden, United Kingdom
• organs None
• Specialty None

A Study of Rituximab in Combination With Fludarabine and Cyclophosphamide in Participants With Chronic Lymphocytic Leukemia and Favorable Somatic Status This multi-center, single-arm study will evaluate the efficacy and safety of rituximab in combination with fludarabine and cyclophosphamide in participants with B-cell chronic lymphocytic ...

• Country Russian Federation
• organs None
• Specialty None

A Study to Evaluate the Pharmacokinetics of LY2624803 in Subjects With Hepatic Impairment The purpose of this study is to evaluate the impact of hepatic dysfunction on the pharmacokinetics and safety of LY2624803 and its major metabolite, LSN2797276.

• Country Germany, Hungary, Russian Federation
• organs None
• Specialty None

Safety and Efficacy of RGH-188 in the Acute Exacerbation of Schizophrenia This is an study to evaluate the safety, efficacy, and tolerability of RGH-188 relative to placebo in adult patients (18-60 years of age) with acute exacerbation of schizophrenia.

• Country India, Malaysia, Russian Federation, Ukraine, United States
• organs None
• Specialty None

Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic Neuralgia The purpose of this study is to evaluate the efficacy of TAK-583, once daily (QD), in relieving pain in subjects with postherpetic neuralgia.

• Country Australia, Bulgaria, Czech Republic, Germany, Netherlands, Poland, Russian Federation, South Africa, United Kingdom
• organs None
• Specialty None

Participant Preference of Subcutaneous (SC) Versus Intravenous (IV) Herceptin (Trastuzumab) in Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer This randomized, open-label, crossover study will evaluate participants' preference and healthcare professional (HCP) satisfaction with SC versus IV Herceptin administration in HER2-positi...

• Country Canada, Denmark, France, Germany, Italy, Poland, Russian Federation, Spain, Sweden, Switzerland, Turkey, United Kingdom
• organs None
• Specialty None

An Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in Combination With Carboplatin This is an open-label dose escalation trial using ABI-007 plus carboplatin.

• Country Russian Federation
• organs None
• Specialty None

A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD) The major purpose of the study is to help determine whether giving the combination of Elzasonan with Zoloft to people with depression is a better treatment than taking Zoloft alone. This s...

• Country Chile, Estonia, Russian Federation, United States
• organs None
• Specialty None

Complications in Hypertension and Obesity The study in aimed to investigate epidemiology of risk factors in Russian Federation its prognostic value aimed on acceptance of national specific definition of metabolic syndrome and guid...

• Country Russian Federation
• organs None
• Specialty None